umbilical cord blood derived natural killer cells / Huzhou Science And Technology Bureau 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
umbilical cord blood derived natural killer cells / Huzhou Science And Technology Bureau
ChiCTR2000031735: Clinical study for natural killer (NK) cells from umbilical cord blood in the treatment of novel coronavirus pneumonia (COVID-19)

Not yet recruiting
N/A
20
China
NK cells were injected by intravenous drip once a day for 2 to 3 times in total, each dose was 4 10^7 pieces /kg body weight,100ml normal saline suspension ;100ml normal saline intravenous drip
Huzhou Central Hospital; Huzhou Central Hospital, Huzhou science and technology bureau
Novel Coronavirus Pneumonia (COVID-19)
 
 

Download Options